Lexi Webster
Meningococcal disease is a rare but serious infection that can lead to severe health complications and even death. The Australian government provides free meningococcal vaccines under the National Immunisation Program for specific risk groups, including Aboriginal and Torres Strait Islander people, people with certain medical conditions, and young adults living in close quarters. Additionally, eligible individuals under 20 years old and refugees can receive free catch-up vaccinations if they missed out during childhood. The Queensland MenB Vaccination Program also offers free vaccines to Queensland residents, targeting infants, children, and adolescents. These initiatives aim to improve vaccine accessibility and protect vulnerable populations from the potentially devastating consequences of meningococcal disease.
| Characteristics | Values |
|---|---|
| Who is eligible for a free meningococcal vaccine in Australia? | Aboriginal and Torres Strait Islander children aged 2 months, 4 months, 6 months (eligible medical conditions) and 12 months. People aged 2 months or older with certain medical conditions. Refugees and other humanitarian entrants of any age. Young people aged 14-16 years. |
| Which vaccine types are free? | Meningococcal B vaccine and Meningococcal ACWY vaccine. |
| Who is not eligible for a free meningococcal vaccine? | Pregnant or breastfeeding women. |
| What are the common side effects of the vaccine? | Irritable, crying, unsettled and generally unhappy. |
| What is the recommended medicine to reduce the risk of fever with the meningococcal B vaccine? | Paracetamol. |
| What is the recommended age for the Bexsero (MenB-MC) vaccine? | Six weeks and above. |
Explore related products
What You'll Learn
- The Meningococcal ACWY vaccine is free for Australian students aged 14-16
- Aboriginal and Torres Strait Islander children are eligible for free MenB vaccines
- The MenB vaccine is available for free to Queensland infants, children and adolescents
- The MenB vaccine is available for purchase on the private market
- The Meningococcal ACWY vaccine is free for eligible people under 20 years old
The Meningococcal ACWY vaccine is free for Australian students aged 14-16
Meningococcal disease is a rare but serious infection that can cause severe scarring, loss of limbs, brain damage, and even death. It occurs when meningococcal bacteria, commonly found in the nose or throat, invade the body and cause serious illness. While most people with meningococcal infection fully recover, some people can develop long-term health complications, including limb deformity, skin scarring, deafness, and brain damage.
The Australian Government recommends meningococcal vaccination for specific groups, including special risk groups such as Aboriginal and Torres Strait Islander people, people with specified medical conditions, laboratory workers who frequently handle Neisseria meningitidis, travellers, and young adults living in close quarters or who are current smokers.
The Meningococcal ACWY vaccine is provided free of charge in schools for Australian students in Year 10, typically aged 14-16. This vaccine is also available for free through other health services, including pharmacies, for adolescents in this age group. The vaccine helps protect against four common types of meningococcal bacteria: A, C, W, and Y.
In addition to the national program, the Queensland MenB Vaccination Program provides free meningococcal B (MenB) vaccines to eligible Queensland infants, children, and adolescents. This program aims to remove financial barriers to immunisation, improve vaccine uptake, and enhance protection against the MenB strain, which has become the most common cause of illness and death from meningococcal disease in Queensland.
It is important to note that meningococcal vaccines may have side effects, and they are not generally recommended for pregnant or breastfeeding women. Anyone considering vaccination should consult their healthcare professional or health service to assess their eligibility and understand the potential risks and benefits.
Best Routes to Fly from UK to Australia
You may want to see also
Explore related products
Aboriginal and Torres Strait Islander children are eligible for free MenB vaccines
Meningococcal disease is a serious infection that can lead to severe health complications and even death. It is caused by the Neisseria meningitidis bacteria, which is commonly found in the nose or throat. While most people recover from meningococcal infection, some may develop long-term health issues such as limb loss, skin scarring, deafness, and brain damage.
The Australian Government's National Immunisation Program (NIP) provides free meningococcal vaccines to eligible individuals. The program recognises that Aboriginal and Torres Strait Islander children face a higher risk of contracting invasive meningococcal disease due to various risk factors, including immune deficiencies, close living quarters, and travel to endemic areas. As a result, Aboriginal and Torres Strait Islander children are eligible for free MenB vaccines under the NIP.
The NIP specifies that Aboriginal and Torres Strait Islander children can receive the MenB vaccine for free at 2 months, 4 months, 6 months (with eligible medical conditions), and 12 months. Additionally, children who missed out on their MenB vaccinations before turning 2 years old are also eligible for free catch-up immunisation. This ensures that all Aboriginal and Torres Strait Islander children have the opportunity to be protected against this serious disease.
The availability of free MenB vaccines for Aboriginal and Torres Strait Islander children is a crucial step towards reducing health disparities and ensuring equitable access to healthcare. By providing free and accessible vaccinations, the Australian Government aims to lower the incidence of meningococcal disease within these communities and improve overall health outcomes.
It is important to note that the eligibility criteria and vaccination schedules may vary slightly between different states and territories in Australia. Therefore, it is always advisable to consult with a healthcare professional or immunisation provider, such as a General Practitioner (GP), to determine the specific requirements and recommendations for your location. They can provide personalised advice and guidance on the immunisation needs of your family.
Flying to Australia: Quarantine Rules and Requirements
You may want to see also
Explore related products
The MenB vaccine is available for free to Queensland infants, children and adolescents
The MenB vaccine is available for free to Queensland infants, children, and adolescents. The Queensland MenB Vaccination Program is the largest state-funded immunisation program ever implemented in Queensland. The program aims to remove financial barriers to immunisation, improve vaccine uptake, and enhance protection against the MenB strain of meningococcal disease.
The vaccine is available for eligible infants aged 6 weeks to less than 12 months. Catch-up immunisation is also offered for children aged 12 months to under 2 years who have not yet received or completed their MenB vaccination. Adolescents aged 15 to 19 years old are also eligible for the free vaccine.
The MenB vaccination program is delivered through Queensland Health-registered vaccine service providers, including general practitioners, community vaccination clinics, and Aboriginal and Torres Strait Islander Health Services. For secondary school students in Year 10, the MenB vaccine is included in Queensland's School Immunisation Program.
In addition to the above-mentioned eligible cohorts, the MenB vaccine is also free for Aboriginal and Torres Strait Islander infants and children under the National Immunisation Program. People aged 2 months or older with certain medical conditions are also eligible for free vaccination under this program.
Meningococcal disease is a serious infection that can lead to severe health outcomes, including significant illness, disability, and even death. The MenB strain is currently the most common cause of illness and death among all strains of meningococcal disease in Queensland. Therefore, the availability of the free MenB vaccine in Queensland is crucial in protecting vulnerable populations and improving health outcomes.
Blended: Australia's Rating and Review
You may want to see also
Explore related products
The MenB vaccine is available for purchase on the private market
The availability of the MenB vaccine on the private market ensures that individuals who do not meet the eligibility criteria for the NIP or the Queensland program can still access the vaccine. This option provides an opportunity for those who wish to proactively protect themselves or their families from meningococcal disease, a severe infection caused by the bacterium Neisseria meningitidis, which can lead to significant health complications and even death.
The decision to purchase the MenB vaccine privately depends on individual circumstances and risk factors. It is important to consult with a healthcare provider, such as a General Practitioner (GP), to discuss the need for private immunisation and the associated costs. They can provide personalised advice and guidance based on an individual's or family's specific situation.
While the private market offers an alternative for those who do not qualify for the free vaccination programs, it is important to note that the Australian government prioritises the immunisation of high-risk groups through the NIP and state-funded initiatives like the Queensland MenB Vaccination Program. These programs aim to remove financial barriers and improve vaccine uptake among vulnerable populations.
By making the MenB vaccine available for purchase on the private market, Australia ensures that individuals who are not covered by the NIP or state-specific programs can still access the vaccine and take proactive measures to protect their health against meningococcal disease.
Med School Tuition Fees in Australia: Are Locals Exempt?
You may want to see also
Explore related products
The Meningococcal ACWY vaccine is free for eligible people under 20 years old
Meningococcal disease is a rare but serious infection that can lead to severe health issues such as limb deformity, skin scarring, deafness, brain damage, and even death. It is caused by Neisseria meningitidis, with serogroup B being the predominant strain in Australia until 2015. Since then, serogroups W and Y have caused a growing number of invasive disease cases.
The Australian government recognizes the importance of protecting its citizens from meningococcal disease and offers free vaccines under the National Immunisation Program. The Meningococcal ACWY vaccine is provided free of charge for eligible individuals under 20 years of age. This includes adolescents from 15 years old who missed the routine adolescent dose of the meningococcal ACWY vaccine at 14 to 16 years of age.
The vaccine is accessible through school-based immunization programs for students in Year 10, typically aged 14 to 16 years old. A signed consent form from a parent or guardian is required for students to receive the vaccination at school. Additionally, adolescents can obtain the vaccine free of charge through other health services, including pharmacies.
It is important to note that eligibility for free meningococcal vaccination also extends to specific risk groups. This includes Aboriginal and Torres Strait Islander people, individuals with specified medical conditions, laboratory workers who frequently handle Neisseria meningitidis, travelers, and young adults living in close quarters or who are smokers.
By offering free meningococcal ACWY vaccines to eligible individuals under 20, Australia is taking proactive measures to safeguard the health and well-being of its citizens, particularly young people, against this serious disease.
Why Australia Says No to Nuclear Power
You may want to see also
Frequently asked questions
The meningococcal vaccine is free for specific groups under the National Immunisation Program. This includes Aboriginal and Torres Strait Islander children aged 2 months, 4 months, 6 months (eligible medical conditions) and 12 months, and people aged 2 months or older with certain medical conditions. Young people aged 14-16 years can get the free meningococcal ACWY vaccine at school in year 10. Refugees and other humanitarian entrants of any age can also get free catch-up vaccinations if they did not receive these vaccines in childhood.
Eligibility for the free meningococcal vaccine in Australia is determined by the National Immunisation Program and varies based on factors such as age, medical conditions, and risk factors. Adolescents from 15 years of age who missed their adolescent dose of the meningococcal ACWY vaccine at 14-16 years may be eligible for a free catch-up vaccination. Additionally, Aboriginal and Torres Strait Islander children who missed their meningococcal B vaccines up until they turn 2 years of age may be eligible.
The meningococcal vaccine is a safe and effective way to protect against meningococcal disease, which is a rare but serious infection. Meningococcal disease can cause severe health complications, including limb loss, deafness, blindness, scarring, organ failure, and even death. Vaccination helps to reduce the risk of these complications and protects against different types of meningococcal bacteria, such as serogroups A, C, W, and Y.
